Form 4: AHR COO Gabriel Willhite Reports RSU Vesting, New Award

American Healthcare REIT's COO, Gabriel M. Willhite, reported routine RSU vesting, associated tax withholdings, and a new RSU award on March 25, 2026.

Summary

• Gabriel M. Willhite, Chief Operating Officer of American Healthcare REIT, Inc. (AHR), reported multiple transactions on March 25, 2026.
• These transactions included the vesting of Restricted Stock Units (RSUs) from awards granted on March 25, 2024, and March 25, 2025.
• Specifically, 9,723 shares of common stock were acquired upon the vesting of RSUs from the 2024 award, and 5,482 shares were acquired from the 2025 award.
• To cover tax obligations associated with these vestings, 4,948 shares and 2,790 shares were disposed of (withheld by the Issuer) at a price of $48.25 per share.
• Additionally, Mr. Willhite received a new award of 10,317 time-based RSUs on March 25, 2026, which will vest ratably over the next three years.
• Following these transactions, Mr. Willhite's direct beneficial ownership of common stock is 145,051 shares, and he holds 10,317 unvested Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting ongoing executive equity compensation and alignment of interests, with no unusual or concerning activity.

Positives

• Acquisition of 9,723 shares of common stock from RSU vesting on March 25, 2026.
• Acquisition of 5,482 shares of common stock from RSU vesting on March 25, 2026.
• Receipt of a new award of 10,317 time-based Restricted Stock Units on March 25, 2026, aligning management interests with shareholder value.
• Increased beneficial ownership of common stock to 145,051 shares after vesting and tax withholding.

Negatives

• Disposition of 4,948 shares of common stock at $48.25 to satisfy tax obligations related to RSU vesting.
• Disposition of 2,790 shares of common stock at $48.25 to satisfy tax obligations related to RSU vesting.

Future Outlook

The reporting person has future RSU vesting events scheduled. The 2024 RSU award has a final vesting on March 25, 2027. The 2025 RSU award has vestings on March 25, 2027, and March 25, 2028. The newly awarded 2026 RSUs will vest ratably on March 10, 2027, March 10, 2028, and March 10, 2029, all subject to continuous employment.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one detailing RSU vesting and tax-related sales, are common in the REIT sector and across publicly traded companies. These transactions reflect standard executive compensation practices designed to align management incentives with long-term shareholder value through equity ownership. The immediate sale of shares to cover tax obligations upon vesting is a typical and expected event, not indicative of a change in management's outlook on the company's prospects.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a significant component of executive compensation is a standard practice across the U.S. real estate investment trust (REIT) industry, similar to companies like Prologis (PLD) or Welltower (WELL).
• The multi-year ratable vesting schedule (e.g., three years) for RSU awards is consistent with industry benchmarks, aiming to promote long-term retention and performance alignment, comparable to equity incentive plans at peer healthcare REITs such as Ventas (VTR) or Healthpeak Properties (PEAK).
• The practice of withholding shares to cover tax obligations upon vesting is a common and efficient mechanism for both the company and the executive, widely adopted by public companies to manage tax liabilities arising from equity compensation.

Stakeholder Impact

• Shareholders: The vesting and award of RSUs can lead to minor dilution as new shares are issued, but it also strengthens the alignment of management's financial interests with long-term shareholder value.
• Employees: The equity compensation structure for the COO may serve as a benchmark or incentive model for other key employees.

Next Steps

• Future vesting of the remaining 2024 RSU award on March 25, 2027.
• Future vesting of the remaining 2025 RSU award on March 25, 2027, and March 25, 2028.
• Future vesting of the 2026 RSU award on March 10, 2027, March 10, 2028, and March 10, 2029.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (RSU vesting, tax withholding, and new awards). Such transactions are pre-scheduled and expected, providing no new material information that would warrant a change in investment recommendation. The filing primarily confirms ongoing management alignment through equity ownership.

Keywords

American Healthcare REIT, AHR, Gabriel Willhite, Form 4, insider transaction, Restricted Stock Units, RSU vesting, stock award, officer compensation, equity compensation, healthcare REIT